Verona Pharma

Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases. They primarily generate revenue through the research, development, and potential commercialization of their lead product candidate, ensifentrine, which targets chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Founded in 2005, the company has a strong pipeline of drug candidates and has established partnerships with various pharmaceutical companies to advance their clinical trials and expand their market reach.

Recent Posts by Verona Pharma

1-6 of 6